tiprankstipranks
Trending News
More News >
AlzeCure Pharma AB (DE:AC6)
FRANKFURT:AC6
Germany Market
Advertisement

AlzeCure Pharma AB (AC6) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
1Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
1Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
AlzeCure Pharma AB’s (AC6) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting AlzeCure Pharma AB is a Sell.
AlzeCure Pharma AB’s (AC6) 20-Day exponential moving average is 0.23, while AlzeCure Pharma AB’s (AC6) share price is €0.2, making it a Sell.
AlzeCure Pharma AB’s (AC6) 50-Day exponential moving average is 0.25, while AlzeCure Pharma AB’s (AC6) share price is €0.2, making it a Sell.

AlzeCure Pharma AB (AC6) Pivot Points

Oct 11, 2025, 10:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.21
0.21
0.21
0.21
0.21
0.21
0.21
Fibonacci
0.21
0.21
0.21
0.21
0.21
0.21
0.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AlzeCure Pharma AB (AC6) Moving Averages

Oct 11, 2025, 10:34 PM
Period
Simple
Exponential
MA5
0.22Sell
0.21Sell
MA10
0.21Sell
0.22Sell
MA20
0.22Sell
0.23Sell
MA50
0.27Sell
0.25Sell
MA100
0.26Sell
0.24Sell
MA200
0.20Sell
0.20Sell
AlzeCure Pharma AB’s (AC6) 10-Day exponential moving average is 0.22, while AlzeCure Pharma AB’s (AC6) share price is €0.2, making it a Sell.
AlzeCure Pharma AB’s (AC6) 100-Day exponential moving average is 0.24, while AlzeCure Pharma AB’s (AC6) share price is €0.2, making it a Sell.
AlzeCure Pharma AB’s (AC6) stock price is €0.2 and AlzeCure Pharma AB’s (AC6) 50-day simple moving average is 0.27, creating a Sell signal.
AlzeCure Pharma AB’s (AC6) stock price is €0.2 and AlzeCure Pharma AB’s (AC6) 100-day simple moving average is 0.26, creating a Sell signal.
AlzeCure Pharma AB’s (AC6) stock price is €0.2 and AlzeCure Pharma AB’s (AC6) 200-day simple moving average is 0.20, creating a Sell signal.

AlzeCure Pharma AB (AC6) Technical Indicators

Oct 11, 2025, 10:34 PM
Name
Value
Implied Action
RSI (14)
43.91
Neutral
STOCH (9,6)
47.62
Neutral
STOCHRSI (14)
44.73
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
32.25
Neutral
Williams %R
-87.01
Buy
CCI (14)
-56.09
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
53.74
Neutral
ROC
0.00
Buy
AlzeCure Pharma AB’s (AC6) Relative Strength Index (RSI) is 43.91, creating a Neutral signal.
AlzeCure Pharma AB’s (AC6) Trend Strength Indicator (ADX) is 32.25, creating a Neutral signal.
AlzeCure Pharma AB’s (AC6) Commodity Channel Index (CCI) is -56.09, creating a Neutral signal.

FAQ

Is AC6 a Buy, Hold, or Sell?
Based on AC6’s technical indicators, AC6 is a Strong Sell.
    What is AC6’s RSI (14)?
    AC6’s RSI (14) is 43.91, which suggests AC6 is a Neutral.
      What is AC6’s MACD?
      AC6’s MACD is -0.02, which suggests AC6 is a Sell.
        What is AC6’s 5-day moving average?
        AC6’s 5-day moving average is 0.22, which suggests AC6 is a Sell.
          What is AC6’s 20-day moving average?
          AC6 20-day moving average is 0.22, which suggests AC6 is a Sell.
            What is AC6’s 50-day moving average?
            AC6’s 50-day moving average is 0.27, which suggests AC6 is a Sell.
              What is AC6’s 200-day moving average?
              AC6’s 200-day moving average is 0.20, which suggests AC6 is a Sell.
                What is AC6’s Williams % R (14)?
                AC6’s Williams % R (14) is -87.01, which suggests AC6 is a Buy.
                  What is AC6’s CCI (14)?
                  AC6’s CCI (14) is -56.09, which suggests AC6 is a Neutral.
                    What is the share price of AlzeCure Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis